Actemra

Actemra is an FDA-approved brand-name prescription drug used to treat rheumatoid arthritis, certain types of  juvenile idiopathic arthritis, giant cell arteritis (inflammation of the arteries), and cytokine release syndrome. In all these conditions, the body's immune system mistakenly attacks cells in the joints or blood vessels, causing swelling, stiffness, and pain. The active ingredient in Actemra, tocilizumab, suppresses the immune system and “slows down” the body's attack on the joints and blood vessels. Actemra is classified as an interleukin-6 (IL-6) receptor antagonist. Actemra is usually administered by a healthcare professional, but a self-injecting Actemra pen is available by prescription.

Este es un medicamento de disponibilidad limitada y no está disponible en la mayoría de las farmacias

Recomendamos que te comuniques con tu seguro médico sobre la disponibilidad de este medicamento.

Acerca de Actemra

Actemra is an FDA-approved brand-name prescription drug used to treat rheumatoid arthritis, certain types of  juvenile idiopathic arthritis, giant cell arteritis (inflammation of the arteries), and cytokine release syndrome. In all these conditions, the body's immune system mistakenly attacks cells in the joints or blood vessels, causing swelling, stiffness, and pain. The active ingredient in Actemra, tocilizumab, suppresses the immune system and “slows down” the body's attack on the joints and blood vessels. Actemra is classified as an interleukin-6 (IL-6) receptor antagonist. Actemra is usually administered by a healthcare professional, but a self-injecting Actemra pen is available by prescription.

Acerca de Actemra

Actemra is an FDA-approved brand-name prescription drug used to treat rheumatoid arthritis, certain types of  juvenile idiopathic arthritis, giant cell arteritis (inflammation of the arteries), and cytokine release syndrome. In all these conditions, the body's immune system mistakenly attacks cells in the joints or blood vessels, causing swelling, stiffness, and pain. The active ingredient in Actemra, tocilizumab, suppresses the immune system and “slows down” the body's attack on the joints and blood vessels. Actemra is classified as an interleukin-6 (IL-6) receptor antagonist. Actemra is usually administered by a healthcare professional, but a self-injecting Actemra pen is available by prescription.